Actively Recruiting
Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
Led by Mansoura University Hospital · Updated on 2025-08-03
50
Participants Needed
1
Research Sites
74 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production and/or exacerbations) due to abnormalities of airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. The presence of non-fully reversible airflow obstruction (FEV1/FVC \< 0.7 post-bronchodilation) measured by spirometry confirms the diagnosis of COPD
CONDITIONS
Official Title
Atopy and Frequency of Exacerbation in Chronic Obstructive Pulmonary Disease Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 40-70 years diagnosed with COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 criteria
You will not qualify if you...
- Patients with known allergic diseases before enrollment
- Patients with associated other chronic respiratory disorders
- Patients with significant comorbidities that could influence respiratory function
- Recent respiratory infections or use of systemic corticosteroids within the last month before enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mohamed AbdElmoniem
Al Mansurah, Egypt, 35516
Actively Recruiting
Research Team
M
Mohamed AbdElmoniem, lecturer
CONTACT
T
Taha Abdelgawad, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here